Citius Pharmaceuticals, Inc. Payments to Acquire and Develop Real Estate
Citius Pharmaceuticals, Inc. (CTXR) reported Payments to Acquire and Develop Real Estate of $2.02 thousand for the 12-month period ending 2012-12-31, per its 10-KT filed 2014-12-29.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireAndDevelopRealEstate · last filed 2014-12-29
- Citius Pharmaceuticals, Inc. payments to acquire and develop real estate for fiscal 2012 was $2.02K.
| Period end | Payments to Acquire and Develop Real Estate 12 month |
|---|---|
| 2012-12-31 | $2.02K 10-KT · filed 2014-12-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |